We further constructed the nomograms based on ANXA2 and other independent prognosis factors (age, gender, grade, stage, and anatomic neoplasm subdivision), in order to demonstrate ANXA2 is important to predict the survival probabilities of PAAD patients. The gene discussed is ANXA2; the disease is pancreatic adenocarcinoma.